Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.002 Å; disorder in main residue; R factor = 0.041; wR factor = 0.105; data-to-parameter ratio = 19.9.
In the title compound, C 20 H 15 N 3 O 3 S, the thiazole ring is approximately planar, with a maximum deviation of 0.003 (1) Å , and makes dihedral angles of 7.44 (6) and 1.88 (6) with the hydroxy-substituted phenyl ring and the pyran ring, respectively. The hydroxyl group is disordered over two sets of sites, with an occupancy ratio of 0.567 (3):0.433 (3). In the crystal, the major disorder component molecules are connected via bifurcated (three-centre) O-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds, generating R 1 2 (6) motifs and resulting in supramolecular chains along the a axis. In the minor occupancy component, however, molecules are connected via C-HÁ Á ÁO hydrogen bonds, forming supramolecular chains along the b axis. Furthermore, the crystal structure is stabilized by -interactions between the thiazole rings [centroid-centroid distance = 3.5476 (7) Å ].
Related literature
For details of coumarin derivatives, see: Raghu et al. (2009) ; Gursoy & Karali (2003) ; Chimenti et al. (2010) ; Kamal et al. (2009) ; Kalkhambkar et al. (2007) . For graph-set notation, see: Bernstein et al. (1995) . For the stability of the temperature controller used in the data collection, see: Cosier & Glazer (1986) . For the synthesis of (E)-2-(1-(3-hydroxyphenyl)ethylidene)hydrazinecarbothioamide, see: Greenbaum et al. (2004) and for that of 3-[!-bromoacetyl coumarin, see: Nadeem et al. (2009) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009 ); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 (Gursoy et al., 2003) and Helicobacter pylori (Chimenti et al., 2010) . These types of compounds are also reported to be good anticancer (Kamal et al., 2009) , analgesic and anti-inflammatory agents (Kalkhambkar et al., 2007) . The title compound is a new derivative of coumarin with the thiazole ring. We present here its crystal structure.
In the molecular structure of the compound, (Fig.1) , the thiazole (S1/N1/C10-C12) ring is approximately planar, with a maximum deviation of 0.003 (1) Å for atom C11. The central thiazole (S1/N1/C10-C12) ring makes dihedral angles of 7.44 (6)° and 1.88 (6)° with the hydroxyl-substituted phenyl (C14-C19) ring and the pyran (O1/C1,C2/C7-C9) ring, respectively. The hydroxyl group is disordered over two sites, with an occupancy ratio 0.567 (3):0.433 (3).
In the crystal packing (Fig. 2) , the major component molecules are connected via bifurcated O3-H1OA···O2 and C19-H19A···O2 hydrogen bonds, generating R 1 2 (6) motifs, (Bernstein et al., 1995) , resulting in supramolecular chains along the a-axis. In the minor component, however, molecules are connected via C19-H19A···O2 hydrogen bonds, forming one-dimensional supramolecular chains along the b-axis (Fig. 3) . Furthermore, the crystal structure is stabilized by π···π interactions between the thiazole (S1/N1/C10-C12) rings [centroid-centroid distance = 3.5476 (7) Å; -x, -y, 1-z].
Experimental (E)-2-(1-(3-Hydroxyphenyl)ethylidene)hydrazinecarbothioamide (Greenbaum et al., 2004 ) and 3-[ω-bromoacetyl coumarin] (Nadeem et al., 2009) were synthesized as reported in the literature. The title compound was prepared by treating (E)-2-(1-(3-hydroxyphenyl)ethylidene)hydrazinecarbothioamide (2.5 mmol) with 3-ω-bromoacetylcoumarin (2.5 mmol) in a chloroform-ethanol (2:1) mixture. The reaction mixture was refluxed for 2-3 hours at 60°C to yield dense yellow precipitates. The precipitates were filtered and boiled with water containing sodium acetate. The title compound was recrystallized as golden crystals from ethanol:chloroform (3:1). 
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